View Press Releases

CD Genomics Revolutionizes Pathogen Discovery with the Launch of Viral Metagenomic Sequencing Service

August 17, 2023

CD Genomics, a global leader in genomic and bioinformatics solutions, is pleased to announce the official launch of its Viral Metagenomic Sequencing service. This state-of-the-art offering represents a major advancement in the field of pathogen research and promises to provide unparalleled insights into viral communities.

Viruses, being the most abundant entities on our planet, play a pivotal role in shaping ecosystems and influencing the health of organisms, including humans. Traditional virology approaches involve isolating and culturing individual viruses, which often hinder a comprehensive view of the intricate viral communities existing in various environments. Viral Metagenomic Sequencing offers a paradigm shift by directly analyzing the genetic material present in a sample without the need for viral isolation.

Traditional virus detection methods have limitations in their ability to identify novel or complex viral pathogens. CD Genomics' Viral Metagenomic Sequencing service overcomes these challenges by utilizing cutting-edge Next-Generation Sequencing (NGS) technology coupled with advanced bioinformatics analysis. The service provides a comprehensive overview of all viral genetic material present in a sample, enabling the detection of both known and previously unknown viruses in a single assay.

The Viral Metagenomic Sequencing service is designed to accommodate various sample types, including clinical samples, environmental samples, and samples from diverse animal species. This versatility makes it an indispensable tool for a wide range of applications, such as epidemiological surveillance, outbreak investigation, and clinical diagnostics.

In the face of emerging infectious diseases, early detection and swift response are critical to preventing widespread outbreaks. CD Genomics' Viral Metagenomic Sequencing service empowers researchers and public health officials to identify emerging pathogens, monitor viral evolution, and enable precision medicine.

In the clinical setting, rapid and accurate diagnosis is paramount to effective patient management. The Viral Metagenomic Sequencing service enhances clinical diagnostics by detecting coinfections, guiding treatment decisions, and improving disease surveillance.

CD Genomics maintains its reputation for excellence in genomic services by employing a team of highly skilled scientists and bioinformaticians. The Viral Metagenomic Sequencing service adheres to stringent quality control processes, ensuring accurate and reliable results for every client.

"At CD Genomics, we are committed to pushing the boundaries of genomics and empowering researchers with cutting-edge technologies. Our Viral Metagenomic Sequencing service represents a significant leap forward in understanding the invisible world of viruses and their impact on life on Earth," stated CD Genomics’ senior scientist.

About CD Genomics

CD Genomics is a leading provider of comprehensive genomic and bioinformatics solutions, serving researchers and clinicians worldwide. With a diverse portfolio of services, including microbial genomics, metagenomics, transcriptomics, epigenomics, and more, CD Genomics remains at the forefront of genomic innovation.


Address: Shirley, NY 11967, USA